Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or-prophylaxis of obesity.
Type:
Grant
Filed:
January 11, 1996
Date of Patent:
December 28, 1999
Assignee:
Novo Nordisk A/S
Inventors:
Niels Korsgaard, Michael Shalmi, Steven Bain, Birgitte Hjort Guldhammer